A Gateway® recombination herpesvirus cloning system with negative selection that produces vectorless progeny

Dusan Kunec, Sandra van Haren, Shane C Burgess, Larry A. Hanson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Crossover recombination based on the lambda phage integration/excision functions enables insertion of a gene of interest into a specific locus by a simple one-step in vitro recombination reaction. Recently, a highly efficient recombination system for targeted mutagenesis, which utilizes lambda phage crossover recombination cloning, has been described for a human herpesvirus 2 bacterial artificial chromosome (BAC). The disadvantages of the system are that it allows only neutral selection (loss of green fluorescent protein) of desired recombinants and that it regenerates herpesvirus progeny containing the BAC sequence inserted in the herpesvirus genome. In this study, the existing channel catfish herpesvirus (CCV) infectious clone (in the form of overlapping fragments) was modified to allow introduction of foreign genes by modified lambda phage crossover recombination cloning. This novel system enables negative and neutral selection and regenerates vectorless herpesvirus progeny. Construction of two CCV mutants expressing lacZ, one from the native CCV ORF5 promoter and the other from the immediate-early cytomegalovirus promoter, demonstrated the efficiency and reliability of this system. This novel cloning system enables rapid incorporation, direct delivery and high-level expression of foreign genes by a herpesvirus. This system has broad utility and could be used to facilitate development of recombinant viruses, viral vectors and better vaccines.

Original languageEnglish (US)
Pages (from-to)82-86
Number of pages5
JournalJournal of Virological Methods
Volume155
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Herpesviridae
Genetic Recombination
Organism Cloning
Ictaluridae
Bacteriophage lambda
Bacterial Artificial Chromosomes
Human Herpesvirus 2
Insertional Mutagenesis
Green Fluorescent Proteins
Cytomegalovirus
Mutagenesis
Vaccines
Clone Cells
Genome
Viruses
Gene Expression
Genes

Keywords

  • Gateway cloning
  • Herpesvirus
  • In vitro recombination
  • Infectious clone
  • Lambda phage integration/excision functions
  • Vaccine development

ASJC Scopus subject areas

  • Virology

Cite this

A Gateway® recombination herpesvirus cloning system with negative selection that produces vectorless progeny. / Kunec, Dusan; van Haren, Sandra; Burgess, Shane C; Hanson, Larry A.

In: Journal of Virological Methods, Vol. 155, No. 1, 01.2009, p. 82-86.

Research output: Contribution to journalArticle

@article{c88a35de785a4885b33e35c51756be65,
title = "A Gateway{\circledR} recombination herpesvirus cloning system with negative selection that produces vectorless progeny",
abstract = "Crossover recombination based on the lambda phage integration/excision functions enables insertion of a gene of interest into a specific locus by a simple one-step in vitro recombination reaction. Recently, a highly efficient recombination system for targeted mutagenesis, which utilizes lambda phage crossover recombination cloning, has been described for a human herpesvirus 2 bacterial artificial chromosome (BAC). The disadvantages of the system are that it allows only neutral selection (loss of green fluorescent protein) of desired recombinants and that it regenerates herpesvirus progeny containing the BAC sequence inserted in the herpesvirus genome. In this study, the existing channel catfish herpesvirus (CCV) infectious clone (in the form of overlapping fragments) was modified to allow introduction of foreign genes by modified lambda phage crossover recombination cloning. This novel system enables negative and neutral selection and regenerates vectorless herpesvirus progeny. Construction of two CCV mutants expressing lacZ, one from the native CCV ORF5 promoter and the other from the immediate-early cytomegalovirus promoter, demonstrated the efficiency and reliability of this system. This novel cloning system enables rapid incorporation, direct delivery and high-level expression of foreign genes by a herpesvirus. This system has broad utility and could be used to facilitate development of recombinant viruses, viral vectors and better vaccines.",
keywords = "Gateway cloning, Herpesvirus, In vitro recombination, Infectious clone, Lambda phage integration/excision functions, Vaccine development",
author = "Dusan Kunec and {van Haren}, Sandra and Burgess, {Shane C} and Hanson, {Larry A.}",
year = "2009",
month = "1",
doi = "10.1016/j.jviromet.2008.09.018",
language = "English (US)",
volume = "155",
pages = "82--86",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A Gateway® recombination herpesvirus cloning system with negative selection that produces vectorless progeny

AU - Kunec, Dusan

AU - van Haren, Sandra

AU - Burgess, Shane C

AU - Hanson, Larry A.

PY - 2009/1

Y1 - 2009/1

N2 - Crossover recombination based on the lambda phage integration/excision functions enables insertion of a gene of interest into a specific locus by a simple one-step in vitro recombination reaction. Recently, a highly efficient recombination system for targeted mutagenesis, which utilizes lambda phage crossover recombination cloning, has been described for a human herpesvirus 2 bacterial artificial chromosome (BAC). The disadvantages of the system are that it allows only neutral selection (loss of green fluorescent protein) of desired recombinants and that it regenerates herpesvirus progeny containing the BAC sequence inserted in the herpesvirus genome. In this study, the existing channel catfish herpesvirus (CCV) infectious clone (in the form of overlapping fragments) was modified to allow introduction of foreign genes by modified lambda phage crossover recombination cloning. This novel system enables negative and neutral selection and regenerates vectorless herpesvirus progeny. Construction of two CCV mutants expressing lacZ, one from the native CCV ORF5 promoter and the other from the immediate-early cytomegalovirus promoter, demonstrated the efficiency and reliability of this system. This novel cloning system enables rapid incorporation, direct delivery and high-level expression of foreign genes by a herpesvirus. This system has broad utility and could be used to facilitate development of recombinant viruses, viral vectors and better vaccines.

AB - Crossover recombination based on the lambda phage integration/excision functions enables insertion of a gene of interest into a specific locus by a simple one-step in vitro recombination reaction. Recently, a highly efficient recombination system for targeted mutagenesis, which utilizes lambda phage crossover recombination cloning, has been described for a human herpesvirus 2 bacterial artificial chromosome (BAC). The disadvantages of the system are that it allows only neutral selection (loss of green fluorescent protein) of desired recombinants and that it regenerates herpesvirus progeny containing the BAC sequence inserted in the herpesvirus genome. In this study, the existing channel catfish herpesvirus (CCV) infectious clone (in the form of overlapping fragments) was modified to allow introduction of foreign genes by modified lambda phage crossover recombination cloning. This novel system enables negative and neutral selection and regenerates vectorless herpesvirus progeny. Construction of two CCV mutants expressing lacZ, one from the native CCV ORF5 promoter and the other from the immediate-early cytomegalovirus promoter, demonstrated the efficiency and reliability of this system. This novel cloning system enables rapid incorporation, direct delivery and high-level expression of foreign genes by a herpesvirus. This system has broad utility and could be used to facilitate development of recombinant viruses, viral vectors and better vaccines.

KW - Gateway cloning

KW - Herpesvirus

KW - In vitro recombination

KW - Infectious clone

KW - Lambda phage integration/excision functions

KW - Vaccine development

UR - http://www.scopus.com/inward/record.url?scp=57549110432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57549110432&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2008.09.018

DO - 10.1016/j.jviromet.2008.09.018

M3 - Article

C2 - 18948138

AN - SCOPUS:57549110432

VL - 155

SP - 82

EP - 86

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1

ER -